NOTE 12 - SEGMENT INFORMATION: Schedule of Segment Income (Tables)

6 Months Ended

Oct. 31, 2021

Tables/Schedules

Schedule of Segment Income

	Three Months Ended October 31,		Six Months Ended October 31,
	2021	2020	2021	2020
Revenues:
Stevioside - third party	$10,001,477	$3,830,340	$16,163,155	$9,020,803
Stevioside - related party	-	502,695	-	2,254,518
Total Stevioside	10,001,477	4,333,035	16,163,155	11,275,321
Corporate and other – third party	106,647	100,809	213,429	198,201
Corporate and other – related party	-	-	-	-
Total Corporate and other	106,647	100,809	213,429	198,201
Total segment and consolidated revenues	$10,108,124	$4,433,844	$16,376,584	$11,473,522
Interest expense:
Stevioside	$(119,934)	$(52,018)	$(190,605)	$(131,125)
Corporate and other	-	-	-	-
Total segment and consolidated interest expense	$(119,934)	$(52,018)	$(190,605)	$(131,125)
Depreciation and amortization:
Stevioside	$312,038	$266,078	$623,881	$519,854
Corporate and other	56,349	56,042	112,942	106,706
Total segment and consolidated depreciation and amortization	$368,387	$322,120	$736,823	$626,560
Income (loss) from operations before income taxes:
Stevioside	$(1,941,725)	$(705,674)	$(2,753,962)	$(1,769,927)
Corporate and other	48,952	47,223	111,072	55,649
Total loss from continuing operations before income taxes	$(1,892,773)	$(658,451)	$(2,642,890)	$(1,714,278)